Shing M Lee

17PUBLICATIONS
61CO-AUTHORS
Radiation therapyPlanning and decision makingMolecular targetsMulticultural, intercultural and cross-cultural studiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 16, 2026
Are safety lead-in phase II clinical trials really safe?

|Jul 17, 2026
Preferences of research participants with experience receiving individual results for future return of results.

|Jun 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

|Apr 27, 2026
Return of results is important to heterogeneous research participants: A single-site survey.

|May 07, 2025
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation.

Gulam A Manji, Liam J Stanton, Angela C Hirbe

|Apr 09, 2024
Dose optimization for cancer treatments with considerations for late-onset toxicities.

Lucie Biard, Anaïs Andrillon, Rebecca B Silva

Pageof 3

Frequent Collaborators

3 joint publications

Dawn L Hershman

3 joint publications

Lucie Biard

2 joint publications

Melissa P Beauchemin

2 joint publications

Morgan R L Lichtenstein